On the morning of August 10, 2018, a jury in the Superior Court of California in San Francisco delivered a verdict that would cost a corporation $289 million and rearrange the public's relationship to its food and its weed killer. The plaintiff was Dewayne "Lee" Johnson, a forty-six-year-old former school groundskeeper from Benicia, California, who had sprayed concentrated Roundup across school grounds hundreds of times — and who was now dying of non-Hodgkin lymphoma, his skin erupting in lesions the jury was shown in photographs. Johnson had asked Monsanto twice whether the product that soaked his coveralls could be causing his cancer. The company never warned him. The jury awarded him $39.2 million in compensatory damages and $250 million in punitive damages, the second figure a deliberate act of punishment for what the jurors had seen in the company's own internal records: discussions of "ghostwriting" the scientific papers that vouched for Roundup's safety, and plans to discredit the international agency that had called its active ingredient a probable human carcinogen. The judge later slashed the punitive award and Johnson accepted a reduced $78 million, but the precedent was set. Tens of thousands of plaintiffs were waiting.
The Johnson verdict is the perfect entry point to this subject precisely because it fuses two questions that must be kept apart to think clearly, and that almost no one keeps apart. The first is a question of science: are genetically modified crops, and the glyphosate sprayed on them, safe to eat and safe to handle? The second is a question of conduct: did Monsanto — the corporation that became the face of agricultural biotechnology — behave honestly, or did it corrupt the very science meant to answer the first question? These are not the same question, and the tragedy of the GMO debate is that the answer to the second has been allowed to stand in for the answer to the first. A public that has read the Monsanto Papers has excellent reasons to distrust Monsanto. Whether it should therefore distrust the molecular biology of a Bt corn plant is a separate matter entirely — and this node is an attempt to hold both in view at once, each at its strongest.
A genetically modified organism, in the agricultural sense that ignited the controversy, is a crop into whose genome a gene has been inserted using recombinant DNA techniques rather than conventional breeding. The era began commercially in 1996, when Monsanto launched Roundup Ready soybeans: soy engineered to carry a bacterial gene that made the plant immune to glyphosate, the active ingredient in the company's flagship herbicide Roundup. A farmer could now spray an entire field and kill every weed while the crop stood untouched. The convenience was enormous, adoption was explosive, and within a decade the great majority of American soy, corn, cotton, and canola was genetically engineered. Roundup Ready was a herbicide-tolerance trait — it sold more herbicide.
The other foundational trait was insect resistance. Bt crops, commercialized for corn and cotton beginning in 1995–96, carry a gene from the soil bacterium Bacillus thuringiensis that makes the plant produce Cry proteins — insecticidal crystals lethal to specific crop-eating caterpillars but, on the evidence, harmless to mammals because they bind to receptors in the insect gut that humans simply do not possess. Bt is, notably, the same organism organic farmers spray on their crops as an approved natural pesticide; the engineered version builds it into the plant. This is the irony at the root of the science debate: the Bt protein had a long safety record before anyone put its gene into corn.
This matters because "GMO" is not one thing. Lumping a vitamin-fortified rice, an insect-resistant cotton, and a herbicide-marketing platform into a single feared acronym is the categorical error that makes the whole conversation go wrong. The technique is neutral; what it is used for ranges from a humanitarian nonprofit project to a strategy for selling more of a patented chemical.
On the narrow question — is it safe to eat food made from approved genetically engineered crops? — the scientific consensus is about as solid as scientific consensus gets, and intellectual honesty requires stating it at full strength. In May 2016, the National Academies of Sciences, Engineering, and Medicine published Genetically Engineered Crops: Experiences and Prospects, a 400-page review by a committee that examined more than 900 studies and twenty years of data across continents where billions of people and animals had eaten GE food. It found no substantiated evidence that GE foods were less safe than their conventional counterparts — no differences in rates of cancer, obesity, kidney disease, allergies, or autism. The American Association for the Advancement of Science board had said the same in 2012: consuming food with ingredients from GM crops is "no riskier" than consuming the same food from conventionally bred crops. A 2014 Pew survey found 88 percent of AAAS scientists held that GM food is safe to eat — a wider gap between scientific and public opinion than on almost any issue, climate change included.
The strongest single emblem of the pro-GMO case is golden rice. Developed by the German scientists Ingo Potrykus and Peter Beyer in the late 1990s with public and Rockefeller Foundation money, golden rice is engineered to produce beta-carotene — the precursor to vitamin A — in the edible grain, giving it a faint gold color. Its purpose is purely humanitarian: vitamin A deficiency blinds and kills hundreds of thousands of children a year in rice-dependent poor countries, and the rice was licensed for free to subsistence farmers. Here was a genetic modification owned by no one's profit motive, designed to save the eyesight and lives of the world's poorest children — and it was opposed for two decades by Greenpeace and allied groups, delayed by regulatory caution, and, after the Philippines finally approved it in 2021, blocked again by a 2024 court order. In 2016 more than a hundred Nobel laureates signed an open letter accusing Greenpeace of a "crime against humanity" for its campaign against it. To the defenders of the technology, golden rice is the case that exposes the anti-GMO movement as ideology indifferent to the body count of its own success.
If GMO food safety is close to settled, the safety of glyphosate — the chemical the most common GMO trait was built to sell — is a live scientific disagreement, and this is where the honest uncertainty actually lives. In March 2015 the International Agency for Research on Cancer (IARC), the cancer arm of the World Health Organization, classified glyphosate as "probably carcinogenic to humans" (Group 2A), citing limited evidence in humans, sufficient evidence in animals, and strong evidence of genotoxicity. The same year, the European Food Safety Authority concluded glyphosate was "unlikely" to pose a carcinogenic hazard, and the U.S. Environmental Protection Agency has repeatedly held it "not likely to be carcinogenic to humans." The world's leading authorities looked at overlapping evidence and reached opposite conclusions.
Some of that gap is explicable and not sinister. IARC assesses hazard — whether a substance can cause cancer at any dose, under any conditions — and by that standard it places glyphosate in the same Group 2A as red meat, very hot beverages, and working as a hairdresser. Regulatory agencies assess risk — whether real-world exposures actually cause harm — and weigh industry-submitted studies IARC excludes by policy. A thing can be a hazard in principle and a negligible risk in practice. But the gap is also the seam through which the conduct question forces itself in, because the question of which studies you trust turns out to depend on who wrote them.
In the course of the Roundup litigation, plaintiffs' attorneys pried loose millions of pages of internal Monsanto records, and what they revealed is the part of this story that no amount of consensus science can wash out. The documents — dubbed the Monsanto Papers — show a company that did not merely defend its product but manufactured the appearance of independent scientific support for it. In one 2015 email, Monsanto scientist William Heydens proposed that the company could "ghost-write" sections of a safety review while outside academics "would just edit & sign their names so to speak," explicitly citing a past paper handled that way to cut costs. The strategy had a name and a contractor: a 2016 review exonerating glyphosate was published as the work of an "Intertek" expert panel of independent scientists, while the documents showed Monsanto personnel had reviewed and edited the manuscripts behind the scenes.
The most vivid single case involves Henry I. Miller, a Stanford-affiliated academic and frequent Forbes columnist. In 2015, as IARC's ruling broke, Miller published a Forbes column attacking the agency — a column that, the documents revealed, Monsanto had largely drafted and handed to him to submit under his own name with no disclosure of the company's role. When The New York Times exposed this in 2017, Forbes deleted every column Miller had ever written for it. Separately, a February 2015 Monsanto memo laid out a coordinated plan to "protect the reputation" of Roundup by orchestrating outrage at IARC and discrediting its scientists — not by refuting the science but by attacking the institution. This is the conduct that the Invisible Control Systems framework describes: not the suppression of a true claim by force, but the manufacture of a scientific consensus through ghostwriting and the destruction of an inconvenient agency's credibility. Whatever the truth about glyphosate, a company confident in its product does not need to write its own independent reviews.
The mirror image of corporate science is activist science, and the GMO debate has its own contested study — one that functions for the anti-GMO movement exactly as Andrew Wakefield's retracted paper functions for the Vaccines & Autism — The Wakefield Affair movement. In September 2012, the French biologist Gilles-Éric Séralini published a two-year feeding study in Food and Chemical Toxicology reporting that rats fed Monsanto's NK603 maize and trace Roundup developed grotesque mammary tumors and died early. Séralini staged the release as a media event, with photographs of tumor-laden rats and an embargo that barred journalists from seeking outside comment — and the images went around the world.
The methodological criticism that followed was, in fairness, severe and largely sound. Séralini used Sprague-Dawley rats, a strain that develops tumors spontaneously at high rates over a two-year lifespan, and he used too few animals per group (ten) to distinguish a treatment effect from that background noise — a design that all but guaranteed alarming-looking tumors regardless of diet. European regulators and six national academies dismissed the conclusions as unsupported. In November 2013 the journal retracted the paper, citing inconclusiveness. But here the conduct question cuts the other way: inconclusiveness is not a recognized ground for retraction under the publishing-ethics standards the journal claimed to follow, the editor who oversaw it had just taken a newly created position with industry ties, and critics across the spectrum saw the retraction itself as a corruption of process. The study was republished, with its raw data, in Environmental Sciences Europe in 2014. The Séralini affair is thus a perfect Rorschach test: to one side it is junk science correctly buried, to the other it is a scientist destroyed for an inconvenient result — and both readings contain real truth.
Beneath the cancer fight runs an older grievance that has nothing to do with toxicology: the corporate ownership of life itself. Because GM seeds are patented, Monsanto required farmers to sign technology agreements forbidding the age-old practice of saving seed from one harvest to plant the next, and it enforced those contracts aggressively, suing farmers whose fields contained its patented genes. The principle reached the Supreme Court in Bowman v. Monsanto (2013), where a 9–0 Court ruled that an Indiana farmer who bought cheap commodity soybeans from a grain elevator and planted them — knowing many would be Roundup Ready — had infringed Monsanto's patent, because the doctrine of patent exhaustion does not let a buyer manufacture new copies of a patented, self-replicating invention. The decision was legally orthodox and culturally explosive: a corporation now held enforceable property rights in the descendants of a plant.
The grievance acquired a darker folklore in the "Terminator" seed — a genetic-use-restriction technology (GURT) that would render harvested seed sterile, making seed-saving biologically impossible. It became the anti-GMO movement's defining nightmare. Yet the crucial fact is that Terminator technology was never commercialized: amid global outrage, Monsanto publicly pledged in 1999 not to deploy it, and no company ever has. The most feared GMO is one that does not exist in any field — a useful caution that the debate's emotional center and its factual center are not always the same place.
The contested middle ground is sharpest in the claim, associated above all with the Indian activist Vandana Shiva, that Monsanto's Bt cotton drove hundreds of thousands of indebted Indian farmers to suicide — "seeds of suicide," she calls them. The reality resists both the slogan and its dismissal. A 2011 International Food Policy Research Institute assessment found no evidence of a resurgence in farmer suicides attributable to Bt cotton — the suicide crisis predated the seed's 2002 introduction and tracked debt, drought, and credit conditions far more than any trait. Yet the same researchers conceded Bt cotton could indirectly deepen the indebtedness that drives suicides where it was sold on credit into the wrong conditions. The honest verdict is that a real human catastrophe exists and that the single-cause story pinning it on a seed does not survive the data — which is its own lesson about how easily corporate villainy and genuine suffering get welded into a myth that obscures both.
In 2018 the German pharmaceutical giant Bayer — a company whose own history runs back through the IG Farben conglomerate dissolved after Nuremberg — completed its roughly $63 billion acquisition of Monsanto and promptly retired the toxic name. It also inherited the toxic liability: facing more than a hundred thousand Roundup cancer claims, Bayer announced in June 2020 a settlement of up to about $10.9 billion. The corporation that wrote its own safety reviews had become a line item on another corporation's balance sheet, the harm outliving the entity that produced it — the Corporate Personhood & The Corporation thesis that the fine lands on the form while the form simply changes hands. That a pharmaceutical company now owns the agrochemical empire only tightens the knot the Big Pharma and the Vaccine Conspiracy debate describes: the same captured-regulator suspicion, the same industry-funded studies, the same gap between what a public agency certifies and what an international body warns, transposed from the drug to the weed killer.
The deepest thing the saga reveals is a structural trap. The science establishment is, on the food-safety question, almost certainly right — approved GMOs are safe to eat, and golden rice could save children's lives. But the institution asking the public to trust that consensus is the same institutional ecosystem that produced the Monsanto Papers, that let a company ghostwrite the literature and savage the WHO, that turned a captured regulator's verdict into a marketing claim. The precautionary public is not being irrational when it refuses to separate the message from the messenger; it is responding, correctly, to a documented record of being lied to. This is the same wound that runs through Vaccines & Autism — The Wakefield Affair and Water Fluoridation: a genuinely sound scientific claim discredited in the public mind by the genuinely untrustworthy conduct of the institutions delivering it. And it is the same Malthusian hope and fear that animate the The Club of Rome & The Limits to Growth debate — biotechnology offered as the escape from the food ceiling, and feared as the corporate enclosure of the seed. Monsanto did not poison the science of GMOs. It did something subtler and more lasting: it made the science impossible to believe.